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Centrosomes consist of a pair of cylindrical, microtubule based structures called 
centrioles, surrounded by proteinaceous pericentriolar material (Nigg and 
Holland, 2018). Centrosomes are key regulators of mitotic spindle formation 
and the docking of one of the centrioles on the cell surface allows it to function 
as a basal body for primary cilium formation. In interphase cells, similar to DNA 
replication, the mother centriole-dependent (MCD) pathway of duplication is 
regulated to occur once per cell cycle in order to ensure monociliation and 
prevent abnormal mitoses resulting from spindle defects caused by numerical 
aberrations in centrosomes (Nigg and Holland, 2018).  
 
While centrioles are normally duplicated only once per cell cycle, multiciliated 
cells (MCCs), characterized by the projection of dozens to hundreds of motile 
cilia, have the unique requirement of massive centriolar expansion in order to 
generate the basal bodies required for multiciliation (Spassky and Meunier, 
2017). MCCs promote luminal flow in the brain ventricle, airways, oviducts and 
epididymis, and defects in this cell type are associated with a rare ciliopathy, 
termed Reduced Generation of Multiple motile Cilia (RGMC) (Boon et al., 2014; 
Wallmeier et al., 2014). RGMC patients present with hydrocephalus, severe 
respiratory distress and infertility, likely all resulting from the loss of MCC 
function.  
 
In order to more efficiently amplify the multiple centrioles needed to form the 
basal bodies, MCCs utilize the MCD pathway, but appear to rely primarily on an 
additional deuterosome-dependent (DD) pathway (Al Jord et al., 2014; Zhao et 
al., 2013). Deuterosomes are poorly characterized electron dense structures 
that mediate centriole amplification. DD mediated amplification is regulated in a 
stepwise manner and controlled by numerous cell cycle components, including 
CDK1, CDK2, PLK1 and the APC/C cyclosome, many of which normally 
regulate centrosome duplication, mitotic progression and chromosome 
segregation in cycling cells (Al Jord et al., 2017; Vladar et al., 2018). The 
coordinated, stepwise assembly of deuterosomes and the involvement of key 
cell cycle regulators suggests the existence of deuterosome checkpoints, 
analogous to those that monitor DNA integrity or centrosome duplication in 
mitotic cells.  
 
Recent work in frogs, zebrafish and mice identified the Geminin family proteins 
GEMC1 (encoded by GMNC and called Gmnc in fish) and MCIDAS (also called 
IDAS in humans, Multicilin in frogs and Mcidas in fish) as key activators of the 
MCC transcriptional cascade, that includes the specific genes involved in the 
DD pathway of centrosome amplification (Arbi et al., 2016; Ma et al., 2014; 
Terre et al., 2016; Zhou et al., 2015). The Geminin family members are 
characterized by a central coiled coil (CC) domain that facilitates their homo and 
heterodimerization. In Geminin, this domain is required to regulate CDT1, 
ensuring that DNA replication occurs once per cell cycle (Arbi et al., 2017). 
While implicated in cell cycle control through Geminin interactions, Gemc1 and 
Mcidas appear to be expressed exclusively in MCCs in mice (Kyrousi et al., 
2015). The encoded proteins contain the central Geminin-like coiled coil 
domain, as well as a C-terminal domain absent from Geminin, dubbed the TIRT 
domain, due to a repeated amino acid motif, that interacts with heterodimers of 
either E2F4 or E2F5 and DP1 (Arbi et al., 2016; Ma et al., 2014; Terre et al., 
2016; Zhou et al., 2015). Both GEMC1 and MCIDAS are necessary for MCC 
differentiation and their ectopic expression is sufficient to activate the 
transcriptional program and drive multiciliogenesis. As neither protein has a 
recognizable DNA binding domain, the E2F4/5-DP1 factors are presumably the 
primary contact point for transcriptional activation. Consistent with this, reduced 
dosage both of E2F4 and E2F5 led to defects in MCC formation in some tissues 
of the mouse (Danielian et al., 2007; Danielian et al., 2016).  
 
The current model of MCC differentiation posits that the inhibition of NOTCH 
results in the activation of GMNC, which initiates the MCC transcriptional 
program through its interactions with E2F4/5-DP1 (Spassky and Meunier, 
2017). This is followed by the activation of MCIDAS that also uses E2F4/5-DP1 
to sustain a transcriptional cascade involving the FOXJ1, FOXN4, Myb, p73 and 
RFX2/3 transcription factors, and likely many additional regulators that remain 
to be identified. This model therefore predicts that MCCs in every tissue in 
which they are present will require some combination of E2F4-DP1 and E2F5-
DP1. However, due to the complications of deleting both factors in all MCC 
containing tissues of the mouse, it has remained an open question whether that 
is indeed the case.  
 
Now, work from Sudipto Roy's lab sheds some light on this question using 
CRISPR/CAS9 engineered zebrafish with mutations in E2f4, E2f5 or both 
factors (Chong et al., 2018). While E2F4 has been considered the more 
important factor in mice, where it is essential for MCC generation in the airway, 
E2f4 null zebrafish are fully competent to generate MCCs in the pronephric 
ducts and the nasal placode. In contrast, E2f5 was absolutely required for 
pronephric MCCs and E2f5 mutants also showed a reduction in MCC numbers 
in the nose. Of note, the defects of E2f5 mutants in the pronephric duct could 
be rescued by ectopic E2f4 expression, indicating that relative expression 
levels, rather than specific functions of either protein may explain the apparent 
specificity. The deletion of both genes led to a complete absence of MCCs in all 
tissues, demonstrating that while there are some tissue specific differences, 
some level of either E2f4 or E2f5 is required for MCCs in all tissues of the fish 
where they are known to differentiate.  
 
Notably, the investigators also used the mutant fish to address the influence of 
E2f4 and E2f5 on the activation of gmnc and mci during multiciliogenesis. They 
found that the activation of gmnc was independent of both proteins, but that 
Gmnc required E2fs to activate mci and other downstream genes. This further 
supports the idea that Gmnc is the primary first responder to cell fate signals, 
such as Notch inhibition, and that this step is E2F4/5 independent. Gmnc then 
initiates the E2F4/5- dependent activation of Mci, and other transcriptional 
activators, that subsequently induce key components of the MCC differentiation 
program.  
 
Similar to E2f4 and E2f5, the level of redundancy between Gmnc and Mci 
remains unclear. The analysis of expression in zebrafish revealed that Mci is 
not detectably expressed in the nasal placode MCCs, indicating that Gmnc is 
sufficient and Mci may be highly, or completely, redundant with Gmnc and 
subject to differential regulation. This could correspond to the relative cilia 
numbers needed in particular MCC types or the relative contribution of other 
transcription factors expressed in a given tissue.  
 
The latter conclusion is potentially consistent with another new report from the 
Roy lab describing the phenotypes of Mcidas knockout mice (Lu et al., in 
press). The deletion of Mcidas in the mouse led to defects in MCC formation as 
expected, however, in contrast to Gemc1 knockouts, MCCs were specified and 
key transcription factors, such as FOXJ1, were expressed at apparently normal 
levels. This and other data led to a model of stepwise activation of the MCC 
program with Gemc1 using primarily E2F5 to specify MCC precursors and 
activate MCIDAS that through the use of both E2F4/5 activates the expression 
of genes needed for the DD pathway for MCC differentiation.  
 
While the zebrafish work clarifies a requirement for either E2F4 or E2F5 for the 
generation of all MCCs and identifies Mci-independent MCC differentiation in 
the nasal placode, many questions still remain. Do these observations extend to 
mice, where in contrast to fish, GEMC1 shows preference for E2F5 binding? 
Given that GEMC1/ Gmnc and MCIDAS/Mci appear to regulate distinct targets 
in their respective organism, it seems unlikely that differential E2F binding is the 
sole determinant of target gene specificity, so what other factors are involved? 
How do Notch inhibition, or other signals, activate Gmnc expression? Do 
heterodimers of Gmnc and Mci have distinct functions in the transition from 
specification to multiciliation? The comparative analysis of zebrafish, mice and 
other systems will no doubt continue to be important for addressing these 
questions and unraveling the complexity and diversity of the MCC differentiation 
program.  
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